Total Funding
81
27
Total FundingGrant raised
Growth Score
-4 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1253867
NanoCytomics develops a technology platform within the field of nanocytology.
- John Hart: President & CEOPast Role: Cardinal Health, Vice President, Strategy and Business Development, Cardinal e-business
Hariharan Subramanian, PhD: Co-Founder and Chief Technology OfficerPast Role: Briteseed, VP of Research and Development
About the Company
NanoCytomics creates a technological platform for the study of nano cytology. They are the creators of a medical innovation aimed at raising the survival rate for cancer patients. The technology developed by their firm enables patients to access creative cancer treatment by providing creative, precise, economical, non-invasive diagnostics for use
in primary care. It also uses optical imaging and sensing technologies to explore the architecture and activities of cells. and health services.
